메뉴 건너뛰기




Volumn 1304, Issue , 2015, Pages 93-98

Neurofilament light chain determination from peripheral blood samples

Author keywords

Axonal damage; Biomarker; Cerebrospinal fluid (CSF); Electrochemiluminescence; Neurofilament light chain (NfL); Serum

Indexed keywords

ABSORBENT; MONOCLONAL ANTIBODY; NEUROFILAMENT LIGHT CHAIN; NEUROFILAMENT PROTEIN; POLYSORBATE 20; STREPTAVIDIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NEUROFILAMENT PROTEIN L;

EID: 84938857445     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2015_206     Document Type: Article
Times cited : (12)

References (20)
  • 1
    • 15944409728 scopus 로고    scopus 로고
    • Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
    • Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233:183–198
    • (2005) J Neurol Sci , vol.233 , pp. 183-198
    • Petzold, A.1
  • 2
    • 33645806333 scopus 로고    scopus 로고
    • Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
    • Brettschneider J, Petzold A, Junker A, Tumani H (2006) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler 12:143–148
    • (2006) Mult Scler , vol.12 , pp. 143-148
    • Brettschneider, J.1    Petzold, A.2    Junker, A.3    Tumani, H.4
  • 3
    • 65449184529 scopus 로고    scopus 로고
    • EFNS guidelines on disease-specific CSF investigations
    • Deisenhammer F, Egg R, Giovannoni G et al (2009) EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 16:760–770
    • (2009) Eur J Neurol , vol.16 , pp. 760-770
    • Deisenhammer, F.1    Egg, R.2    Giovannoni, G.3
  • 4
    • 77949889957 scopus 로고    scopus 로고
    • Cerebrospinal fluid neurofilament: The biomarker that will resuscitate the ‘Spinal Tap’
    • Giovannoni G (2010) Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the ‘Spinal Tap’. Mult Scler 16:285–286
    • (2010) Mult Scler , vol.16 , pp. 285-286
    • Giovannoni, G.1
  • 5
    • 79551478161 scopus 로고    scopus 로고
    • Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
    • Gunnarsson M, Malmestrom C, Axelsson M et al (2011) Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 69:83–89
    • (2011) Ann Neurol , vol.69 , pp. 83-89
    • Gunnarsson, M.1    Malmestrom, C.2    Axelsson, M.3
  • 6
    • 77649181283 scopus 로고    scopus 로고
    • A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein
    • Kuhle J, Regeniter A, Leppert D et al (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J Neuroimmunol 220:114
    • (2010) J Neuroimmunol , vol.220 , pp. 114
    • Kuhle, J.1    Regeniter, A.2    Leppert, D.3
  • 7
    • 79954568567 scopus 로고    scopus 로고
    • Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
    • Kuhle J, Leppert D, Petzold A et al (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76:1206–1213
    • (2011) Neurology , vol.76 , pp. 1206-1213
    • Kuhle, J.1    Leppert, D.2    Petzold, A.3
  • 9
    • 67650234232 scopus 로고    scopus 로고
    • CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barre syndrome
    • Petzold A, Brettschneider J, Jin K et al (2009) CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barre syndrome. Muscle Nerve 40:42–49
    • (2009) Muscle Nerve , vol.40 , pp. 42-49
    • Petzold, A.1    Brettschneider, J.2    Jin, K.3
  • 10
    • 0142011171 scopus 로고    scopus 로고
    • Elevated neurofilament levels in neurological diseases
    • Norgren N, Rosengren L, Stigbrand T (2003) Elevated neurofilament levels in neurological diseases. Brain Res 987:25–31
    • (2003) Brain Res , vol.987 , pp. 25-31
    • Norgren, N.1    Rosengren, L.2    Stigbrand, T.3
  • 11
    • 65349157666 scopus 로고    scopus 로고
    • Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
    • Teunissen CE, Iacobaeus E, Khademi M et al (2009) Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 72:1322–1329
    • (2009) Neurology , vol.72 , pp. 1322-1329
    • Teunissen, C.E.1    Iacobaeus, E.2    Khademi, M.3
  • 14
    • 0030000479 scopus 로고    scopus 로고
    • Quantification of cytokine messenger RNA in transfected human T cells by RT-PCR and an automated electrochemiluminescence-based post-PCR detection system
    • Motmans K, Raus J, Vandevyver C (1996) Quantification of cytokine messenger RNA in transfected human T cells by RT-PCR and an automated electrochemiluminescence-based post-PCR detection system. J Immunol Methods 190:107–116
    • (1996) J Immunol Methods , vol.190 , pp. 107-116
    • Motmans, K.1    Raus, J.2    Vandevyver, C.3
  • 15
    • 0030027503 scopus 로고    scopus 로고
    • Immunomagneticelectrochemiluminescent detection of Escherichiacoli O157 and Salmonella typhimurium in foods and environmental water samples
    • Yu H, Bruno JG (1996) Immunomagneticelectrochemiluminescent detection of Escherichiacoli O157 and Salmonella typhimurium in foods and environmental water samples. Appl Environ Microbiol 62:587–592
    • (1996) Appl Environ Microbiol , vol.62 , pp. 587-592
    • Yu, H.1    Bruno, J.G.2
  • 16
    • 0031454886 scopus 로고    scopus 로고
    • Development of an equilibrium immunoassay using electrochemiluminescent detection for a novel recombinant protein product and its application to pre-clinical pro duct developme nt
    • Grimshaw C, Gleason C, Chojnicki E, Young J (1997) Development of an equilibrium immunoassay using electrochemiluminescent detection for a novel recombinant protein product and its application to pre-clinical pro duct developme nt. J Pharm Biomed Anal 16:605–612
    • (1997) J Pharm Biomed Anal , vol.16 , pp. 605-612
    • Grimshaw, C.1    Gleason, C.2    Chojnicki, E.3    Young, J.4
  • 17
    • 0033952003 scopus 로고    scopus 로고
    • Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphylococcal enterotoxin B
    • Kijek TM, Rossi CA, Moss D, Parker RW, Henchal EA (2000) Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphylococcal enterotoxin B. J Immunol Methods 236:9–17
    • (2000) J Immunol Methods , vol.236 , pp. 9-17
    • Kijek, T.M.1    Rossi, C.A.2    Moss, D.3    Parker, R.W.4    Henchal, E.A.5
  • 18
    • 21844438460 scopus 로고    scopus 로고
    • Comparison of electrochemiluminescence assay and ELISA for the detection  of Clostridium botulinum type B neurotoxin
    • Guglielmo-Viret V, Attree O, Blanco-Gros V, Thullier P (2005) Comparison of electrochemiluminescence assay and ELISA for the detection  of Clostridium botulinum type B neurotoxin. J Immunol Methods 301:164–172
    • (2005) J Immunol Methods , vol.301 , pp. 164-172
    • Guglielmo-Viret, V.1    Attree, O.2    Blanco-Gros, V.3    Thullier, P.4
  • 19
    • 35549010108 scopus 로고    scopus 로고
    • Comparison of an electrochemiluminescence assay in plate format over a colorimetric ELISA, for the detection of ricin B chain (RCA-B)
    • Guglielmo-Viret V, Thullier P (2007) Comparison of an electrochemiluminescence assay in plate format over a colorimetric ELISA, for the detection of ricin B chain (RCA-B). J Immunol Methods 328:70–78
    • (2007) J Immunol Methods , vol.328 , pp. 70-78
    • Guglielmo-Viret, V.1    Thullier, P.2
  • 20
    • 84884497586 scopus 로고    scopus 로고
    • Dobson R et al (2013)Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
    • Gaiottino J, Norgren N, Dobson R et al (2013)Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One 8:e75091
    • Plos One , vol.8
    • Gaiottino, J.1    Norgren, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.